Flaraxin Suppositories

Flaraxin Suppositories

from 100.00

FLARAXIN Suppositories are antiviral, anti-inflammatory, anti-cancer, anti-fungal, immunomodulatory, stimulate the production of interferon and the tumor necrosis factor, cause lysis of mutated cells of the damaged organs, reduce allergic reactions, suppress the development of pathogenic microflora and strengthen the protective properties of the body.

They can also be used for the treatment of benign and malignant diseases of the female reproductive system as well as in complex treatment in combination with radiation and chemotherapy, with chronic benign processes of the reproductive system (colpitis, cervicitis, chronic adnexitis, candidamycosis, viral papillomatosis, cervical erosion, endometriosis, cervical canal and intestinal polyposis, uterine fibroids), mastopathy, thyroid disease euthoriosis, hypothyroidism).

Description

FLARAXIN Suppositories are antiviral, anti-inflammatory, anti-cancer, immunomodulatory, stimulate the production of interferon, reduce allergic reactions, suppress the development of pathogenic microflora and strengthen the protective properties of the body. FLARAXIN Suppositories – can be widely used for prophylactics and treatment of inflectional, somatic, viral and oncologic diseases. They are a preparation of organic origin. The acting components are organic polyphenols, obtained through our vacuum-condensation technology.

Pharmacological properties

FLARAXIN has a wide range of biological effects: it is antioxidant, immunomodulatory, has antiviral and antitumor effects. FLARAXIN is effective in:

Stimulating the production of endogenous interferon and tumor necrosis factor;

Normalising the immunological background in cancer patients;

Normalising the ratios of immunocompetent CD4 / CD8 cells (helpers-suppressors) and an increase in the number of natural killers (NK cells);

FLARAXIN is useful in treatment of various clinical and morphological forms of malignant neoplasms, for the treatment of benign tumors, as a carcinostatic and antiretroviral drug. Immunobiochemical studies established the ability of FLARAXIN to bind to oncophethal proteins, causing their microdenatural damage, while the carcinostatic properties are explained by the effects of FLARAXIN on the metabolism of tumor cells, causing their death.

A positive therapeutic effect in patients with neglected forms of the tumor process is accompanied by restraint of metastatic activity and elimination of autoimmune disorders, significantly improving the quality of life of patients of this category.

It is advisable to use FLARAXIN in various combinations with radiation and chemotherapy. It is clinically justifiable and highly effective to use it as a means of adjuvant and neoadjuvant therapy. In the first case, prerequisites for successful surgical intervention are created, in the second case, there is no need for preventive chemotherapy treatment.

FLARAXIN actively binds to pathological immune complexes, it is able to prevent the progression of autoimmune diseases in the pathogenesis of which the formation of immune complexes (cirrhoses, hepatitis, chronic nephritis, etc.) takes place.

The above properties of the drug make it possible to use FLARAXIN in the treatment of viral infections of the central nervous system, "slow" viral infections, which include AIDS, multiple sclerosis, etc.